National Heart, Lung, and Blood Institute; Amended Notice of Meeting
---
identifier: "/us/fr/2024-16054"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2024-16054"
section_name: "National Heart, Lung, and Blood Institute; Amended Notice of Meeting"
positive_law: false
currency: "2024-07-22"
last_updated: "2024-07-22"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2024-16054"
document_type: "notice"
publication_date: "2024-07-22"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "89 FR 59124"
fr_volume: 89
---
# National Heart, Lung, and Blood Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Heart, Lung, and Blood Institute Special Emphasis Panel, Catalyze Product Definition, August 15, 2024, 10:00 a.m. to 2:00 p.m., National Institutes of Health, Rockledge I, 6705 Rockledge Drive, Bethesda, MD 20892 which was published in the *Federal Register* on July 16, 2024, 89 FR 57916.
This meeting is being amended due to a change the meeting date. The meeting will be held on September 13, 2024, from 10:00 a.m. to 2:00 p.m. The meeting is closed to the public.
Dated: July 17, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee Policy.